hsa-miR-181a-5p is significantly downregulated in glioblastoma tissues compared to control (Fig. 2G); however, there is no statistically significant difference between AKT3 expression value between glioblastoma and non-tumoral tissues (Fig. 2H–I). The gene discussed is AKT3; the disease is glioblastoma.